There is no certain way to tell out which prostate cancer may turn out fatal and which not. However, now researches have found that level changing of prostrate specific antigen (PSA) can be helpful in predicting about the survival years of a prostate cancer patient.
These researchers found during the course of their study that 92 percent of the patients with slower rise in PSA were alive after 25 years. On the contrary, only 54 percent of the patients with higher rise in PSA survived after 25 years.
With this new finding, it would definitely be easy for the doctors to predict precisely how long the patients with prostate cancer would survive.
Image credit: combat-cancer
Via: webmd